{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:30:32Z","timestamp":1792564232413,"version":"4.5.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00417-025-07010-5","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T08:17:24Z","timestamp":1765009044000},"page":"603-615","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ophthalmic complications of radiotherapy"],"prefix":"10.1007","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0381-2744","authenticated-orcid":false,"given":"Mark","family":"Beecher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khizar","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghu","family":"Gowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weng Onn","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Selva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"7010_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","volume":"21","author":"B Emami","year":"1991","unstructured":"Emami B et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109\u2013122","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0167-8140(94)90005-1","volume":"30","author":"GL Jiang","year":"1994","unstructured":"Jiang GL et al (1994) Radiation-induced injury to the visual pathway. Radiother Oncol 30:17\u201325","journal-title":"Radiother Oncol"},{"key":"7010_CR3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/0360-3016(94)90348-4","volume":"30","author":"JT Parsons","year":"1994","unstructured":"Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR (1994) Severe dry-eye syndrome following external beam irradiation. Int J Radiat Oncol Biol Phys 30:775\u2013780","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR4","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.ijrobp.2011.05.026","volume":"82","author":"N Bhandare","year":"2012","unstructured":"Bhandare N et al (2012) Severe dry eye syndrome after radiotherapy for head-and-neck tumors. Int J Radiat Oncol Biol Phys 82:1501\u20131508","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR5","doi-asserted-by":"publisher","first-page":"20130459","DOI":"10.1259\/bjr.20130459","volume":"86","author":"SS Batth","year":"2013","unstructured":"Batth SS et al (2013) Clinical-dosimetric relationship between lacrimal gland dose and ocular toxicity after intensity-modulated radiotherapy for sinonasal tumours. Br J Radiol 86:20130459","journal-title":"Br J Radiol"},{"key":"7010_CR6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/0360-3016(94)90347-6","volume":"30","author":"JT Parsons","year":"1994","unstructured":"Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR (1994) Radiation retinopathy after external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 30:765\u2013773","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0360-3016(99)00057-7","volume":"44","author":"A Takeda","year":"1999","unstructured":"Takeda A et al (1999) Late retinal complications of radiation therapy for nasal and paranasal malignancies: relationship between irradiated-dose area and severity. Int J Radiat Oncol Biol Phys 44:599\u2013605","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR8","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/0360-3016(91)90025-Y","volume":"20","author":"KJ Minehan","year":"1991","unstructured":"Minehan KJ et al (1991) Local control and complications after radiation therapy for primary orbital lymphoma: a case for low-dose treatment. Int J Radiat Oncol Biol Phys 20:791\u2013796","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0167-8140(00)00328-5","volume":"59","author":"SL Stafford","year":"2001","unstructured":"Stafford SL et al (2001) Orbital lymphoma: radiotherapy outcome and complications. Radiother Oncol 59:139\u2013144","journal-title":"Radiother Oncol"},{"key":"7010_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.radonc.2008.09.011","volume":"90","author":"H Nam","year":"2009","unstructured":"Nam H, Ahn YC, Kim YD, Ko Y, Kim WS (2009) Prognostic significance of anatomic subsites: results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma. Radiother Oncol 90:236\u2013241","journal-title":"Radiother Oncol"},{"key":"7010_CR11","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.ijrobp.2011.12.097","volume":"84","author":"M Kaushik","year":"2012","unstructured":"Kaushik M, Pulido JS, Schild SE, Stafford S (2012) Risk of radiation retinopathy in patients with orbital and ocular lymphoma. Int J Radiat Oncol Biol Phys 84:1145\u20131150","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR12","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.ijrobp.2009.07.1753","volume":"76","author":"C Mayo","year":"2010","unstructured":"Mayo C et al (2010) Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys 76:S28-35","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15071999","author":"B Kinaci-Tas","year":"2023","unstructured":"Kinaci-Tas B, Alderliesten T, Verbraak FD, Rasch CRN (2023) Radiation-induced retinopathy and optic neuropathy after radiation therapy for brain, head, and neck tumors: a systematic review. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15071999","journal-title":"Cancers (Basel)"},{"key":"7010_CR14","first-page":"3647462","volume":"2022","author":"YL Wu","year":"2022","unstructured":"Wu YL et al (2022) Long-term evaluation and normal tissue complication probability (NTCP) models for predicting radiation-induced optic neuropathy after intensity-modulated radiation therapy (IMRT) for nasopharyngeal carcinoma: a large retrospective study in China. J Oncol 2022:3647462","journal-title":"J Oncol"},{"key":"7010_CR15","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1177\/1533034617711613","volume":"16","author":"O Ozkaya Akagunduz","year":"2017","unstructured":"Ozkaya Akagunduz O et al (2017) Evaluation of the radiation dose-volume effects of optic nerves and chiasm by psychophysical, electrophysiologic tests, and optical coherence tomography in nasopharyngeal carcinoma. Technol Cancer Res Treat 16:969\u2013977","journal-title":"Technol Cancer Res Treat"},{"key":"7010_CR16","doi-asserted-by":"publisher","first-page":"106213","DOI":"10.1016\/j.envint.2020.106213","volume":"146","author":"EA Ainsbury","year":"2021","unstructured":"Ainsbury EA et al (2021) Radiation-induced lens opacities: epidemiological, clinical and experimental evidence, methodological issues, research gaps and strategy. Environ Int 146:106213","journal-title":"Environ Int"},{"key":"7010_CR17","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.ijrobp.2004.07.664","volume":"61","author":"AT Monroe","year":"2005","unstructured":"Monroe AT, Bhandare N, Morris CG, Mendenhall WM (2005) Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys 61:856\u2013864","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR18","volume-title":"Radiobiology for the radiologist","author":"EJ Hall","year":"2018","unstructured":"Hall EJ, Giaccia AJ (2018) Radiobiology for the radiologist. Lippincott Williams & Wilkins, Philadelphia"},{"key":"7010_CR19","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.ophtha.2006.10.039","volume":"114","author":"Group C.O.M.S","year":"2007","unstructured":"Group C.O.M.S (2007) Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27. Ophthalmology 114:1363\u20131371","journal-title":"Ophthalmology"},{"key":"7010_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ijrobp.2023.06.007","volume":"119","author":"CJ Shen","year":"2023","unstructured":"Shen CJ et al (2023) Retinopathy, optic neuropathy, and cataract in childhood cancer survivors treated with radiation therapy: A PENTEC comprehensive review. Int J Radiat Oncol Biol Phys 119:431\u201345","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1600-0420.2006.00822.x","volume":"85","author":"SR Durkin","year":"2007","unstructured":"Durkin SR, Roos D, Higgs B, Casson RJ, Selva D (2007) Ophthalmic and adnexal complications of radiotherapy. Acta Ophthalmol Scand 85:240\u2013250","journal-title":"Acta Ophthalmol Scand"},{"key":"7010_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13014-018-1045-7","volume":"13","author":"K Fukutsu","year":"2018","unstructured":"Fukutsu K, Kase S, Ishijima K, Kinoshita R, Ishida S (2018) The clinical features of radiation cataract in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma. Radiat Oncol 13:95","journal-title":"Radiat Oncol"},{"key":"7010_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4236\/jct.2016.73018","volume":"7","author":"V Tseng","year":"2016","unstructured":"Tseng V, Coleman A, Zhang Z, McCannel T (2016) Complications from plaque versus proton beam therapy for choroidal melanoma: a qualitative systematic review. J Cancer Ther 7:169\u2013185","journal-title":"J Cancer Ther"},{"key":"7010_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.radonc.2021.11.007","volume":"166","author":"F Buonanno","year":"2022","unstructured":"Buonanno F et al (2022) Local tumor control and treatment related toxicity after plaque brachytherapy for uveal melanoma: a systematic review and a data pooled analysis. Radiother Oncol 166:15\u201325","journal-title":"Radiother Oncol"},{"key":"7010_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13014-024-02580-w","volume":"20","author":"Y Miao","year":"2025","unstructured":"Miao Y et al (2025) Efficacy and safety of proton radiotherapy in treating choroidal melanoma: a systematic review and meta-analysis. Radiat Oncol 20:7","journal-title":"Radiat Oncol"},{"key":"7010_CR26","doi-asserted-by":"publisher","first-page":"5378","DOI":"10.1167\/iovs.17-22557","volume":"58","author":"J Thariat","year":"2017","unstructured":"Thariat J et al (2017) Cataract avoidance with proton therapy in ocular melanomas. Invest Ophthalmol Vis Sci 58:5378\u20135386","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7010_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.icrp.2012.06.018","volume":"41","author":"NJ Kleiman","year":"2012","unstructured":"Kleiman NJ (2012) Radiation cataract. Ann ICRP 41:80\u201397","journal-title":"Ann ICRP"},{"key":"7010_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/08820530500351728","volume":"21","author":"ZK Ferrufino-Ponce","year":"2006","unstructured":"Ferrufino-Ponce ZK, Henderson BA (2006) Radiotherapy and cataract formation. Semin Ophthalmol 21:171\u2013180","journal-title":"Semin Ophthalmol"},{"key":"7010_CR29","first-page":"71","volume":"9","author":"A Baradaran-Rafii","year":"2014","unstructured":"Baradaran-Rafii A, Shirzadeh E, Eslani M, Akbari M (2014) Optical correction of aphakia in children. J Ophthalmic Vis Res 9:71\u201382","journal-title":"J Ophthalmic Vis Res"},{"key":"7010_CR30","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.2147\/OPTH.S219268","volume":"15","author":"NK Sahoo","year":"2021","unstructured":"Sahoo NK, Ranjan R, Tyagi M, Agrawal H, Reddy S (2021) Radiation retinopathy: detection and management strategies. Clin Ophthalmol (Auckland, NZ) 15:3797\u20133809","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"key":"7010_CR31","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ijrobp.2019.06.2540","volume":"105","author":"AW Lee","year":"2019","unstructured":"Lee AW et al (2019) International guideline on dose prioritization and acceptance criteria in radiation therapy planning for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 105:567\u2013580","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ijrobp.2022.07.017","volume":"115","author":"AV Trofimov","year":"2023","unstructured":"Trofimov AV et al (2023) A systematic comparison of dose distributions delivered in 125I plaque brachytherapy and proton radiation therapy for ocular melanoma. Int J Radiat Oncol Biol Phys 115:501\u2013510","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR33","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/eye.2015.109","volume":"29","author":"MJ Sikuade","year":"2015","unstructured":"Sikuade MJ et al (2015) Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma. Eye (Lond) 29:1194\u20131198","journal-title":"Eye (Lond)"},{"key":"7010_CR34","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/S0161-6420(99)90455-4","volume":"106","author":"ES Gragoudas","year":"1999","unstructured":"Gragoudas ES, Li W, Lane AM, Munzenrider J, Egan KM (1999) Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology 106:1571\u20131578","journal-title":"Ophthalmology"},{"key":"7010_CR35","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.ophtha.2009.10.015","volume":"117","author":"CMD Bianciotto","year":"2010","unstructured":"Bianciotto CMD et al (2010) Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma. Ophthalmology 117:1005\u20131012","journal-title":"Ophthalmology"},{"key":"7010_CR36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3129\/i10-111","volume":"46","author":"H Krema","year":"2011","unstructured":"Krema H et al (2011) Factors predictive of radiation retinopathy post (125)iodine brachytherapy for uveal melanoma. Can J Ophthalmol 46:158\u2013163","journal-title":"Can J Ophthalmol"},{"key":"7010_CR37","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1001\/archopht.117.5.609","volume":"117","author":"K G\u00fcnd\u00fcz","year":"1999","unstructured":"G\u00fcnd\u00fcz K et al (1999) Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol 117:609\u2013614","journal-title":"Arch Ophthalmol"},{"key":"7010_CR38","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s00417-016-3429-4","volume":"254","author":"I Seibel","year":"2016","unstructured":"Seibel I et al (2016) Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma. Graefes Arch Clin Exp Ophthalmol 254:1787\u20131792","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7010_CR39","doi-asserted-by":"publisher","first-page":"e1458","DOI":"10.1111\/aos.14814","volume":"99","author":"MV Cicinelli","year":"2021","unstructured":"Cicinelli MV et al (2021) Predictive factors of radio-induced complications in 194 eyes undergoing gamma knife radiosurgery for uveal melanoma. Acta Ophthalmol 99:e1458\u2013e1466","journal-title":"Acta Ophthalmol"},{"key":"7010_CR40","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/s41433-022-02200-5","volume":"37","author":"BE Powell","year":"2022","unstructured":"Powell BE, Chin KJ, Finger PT (2022) Early anti-VEGF treatment for radiation maculopathy and optic neuropathy: lessons learned. Eye (London) 37:866\u201374","journal-title":"Eye (London)"},{"key":"7010_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/IAE.0b013e31814b1b75","volume":"28","author":"N Horgan","year":"2008","unstructured":"Horgan N et al (2008) Early macular morphological changes following plaque radiotherapy for uveal melanoma. Retina (Philadelphia, Pa) 28:263\u2013273","journal-title":"Retina (Philadelphia, Pa)"},{"key":"7010_CR42","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/bjo.2004.052159","volume":"89","author":"PT Finger","year":"2005","unstructured":"Finger PT, Kurli M (2005) Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy. Br J Ophthalmol 89:730\u2013738","journal-title":"Br J Ophthalmol"},{"key":"7010_CR43","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1097\/IAE.0000000000001021","volume":"36","author":"CL Shields","year":"2016","unstructured":"Shields CL et al (2016) Optical coherence tomography angiography of the macula after plaque radiotherapy of choroidal melanoma: comparison of irradiated versus nonirradiated eyes in 65 patients. Retina 36:1493\u20131505","journal-title":"Retina"},{"key":"7010_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ajo.2017.06.008","volume":"181","author":"A Sellam","year":"2017","unstructured":"Sellam A et al (2017) Optical coherence tomography angiography of macular features after proton beam radiotherapy for small choroidal melanoma. Am J Ophthalmol 181:12\u201319","journal-title":"Am J Ophthalmol"},{"key":"7010_CR45","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1167\/iovs.17-22324","volume":"58","author":"A Matet","year":"2017","unstructured":"Matet A, Daruich A, Zografos L (2017) Radiation maculopathy after proton beam therapy for uveal melanoma: optical coherence tomography angiography alterations influencing visual acuity. Invest Ophthalmol Vis Sci 58:3851\u20133861","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7010_CR46","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1097\/IAE.0000000000000844","volume":"35","author":"KK Veverka","year":"2015","unstructured":"Veverka KK, Abouchehade JE, Iezzi R, Pulido JS (2015) Noninvasive grading of radiation retinopathy: the use of optical coherence tomography angiography. Retina 35:2400\u20132410","journal-title":"Retina"},{"key":"7010_CR47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.5301\/ejo.5000670","volume":"26","author":"PT Finger","year":"2016","unstructured":"Finger PT, Chin KJ, Semenova EA (2016) Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study. Eur J Ophthalmol 26:60\u201366","journal-title":"Eur J Ophthalmol"},{"key":"7010_CR48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00417-021-05281-2","volume":"260","author":"HJ Yu","year":"2022","unstructured":"Yu HJ et al (2022) Two-year results for ranibizumab for radiation retinopathy (RRR): a randomized, prospective trial. Graefes Arch Clin Exp Ophthalmol 260:47\u201354","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7010_CR49","first-page":"1877","volume":"7","author":"NV Shah","year":"2013","unstructured":"Shah NV, Houston SK, Markoe A, Murray TG (2013) Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma. Clin Ophthalmol 7:1877\u20131882","journal-title":"Clin Ophthalmol"},{"key":"7010_CR50","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1136\/bjophthalmol-2017-310315","volume":"101","author":"RI Kaplan","year":"2017","unstructured":"Kaplan RI, Chaugule SS, Finger PT (2017) Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab. Br J Ophthalmol 101:1694\u20131698","journal-title":"Br J Ophthalmol"},{"key":"7010_CR51","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/S0161-6420(98)98023-X","volume":"105","author":"PG Hykin","year":"1998","unstructured":"Hykin PG, Shields CL, Shields JA, Arevalo JF (1998) The efficacy of focal laser therapy in radiation-induced macular edema. Ophthalmology 105:1425\u20131429","journal-title":"Ophthalmology"},{"key":"7010_CR52","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ophtha.2013.08.039","volume":"121","author":"SU Shah","year":"2014","unstructured":"Shah SU et al (2014) Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma. Ophthalmology 121:269\u2013275","journal-title":"Ophthalmology"},{"key":"7010_CR53","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamaophthalmol.2019.5132","volume":"138","author":"CL Shields","year":"2020","unstructured":"Shields CL et al (2020) Visual outcome at 4 years following plaque radiotherapy and prophylactic intravitreal bevacizumab (every 4 months for 2 years) for uveal melanoma: comparison with nonrandomized historical control individuals. JAMA Ophthalmol 138:136\u2013146","journal-title":"JAMA Ophthalmol"},{"key":"7010_CR54","first-page":"T2","volume":"114","author":"IK Kim","year":"2016","unstructured":"Kim IK, Lane AM, Jain P, Awh C, Gragoudas ES (2016) Ranibizumab for the prevention of radiation complications in patients treated with proton beam irradiation for choroidal melanoma. Trans Am Ophthalmol Soc 114:T2","journal-title":"Trans Am Ophthalmol Soc"},{"key":"7010_CR55","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.ophtha.2009.01.051","volume":"116","author":"N Horgan","year":"2009","unstructured":"Horgan N et al (2009) Periocular triamcinolone for prevention of macular edema after plaque radiotherapy of uveal melanoma: a randomized controlled trial. Ophthalmology 116:1383\u20131390","journal-title":"Ophthalmology"},{"key":"7010_CR56","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1097\/IAE.0b013e31816b3192","volume":"28","author":"N Horgan","year":"2008","unstructured":"Horgan N et al (2008) Periocular triamcinolone for prevention of macular edema after iodine 125 plaque radiotherapy of uveal melanoma. Retina 28:987\u2013995","journal-title":"Retina"},{"key":"7010_CR57","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1097\/IAE.0b013e3182437e70","volume":"32","author":"MA Materin","year":"2012","unstructured":"Materin MA, Bianciotto CG, Wu C, Shields CL (2012) Sector laser photocoagulation for the prevention of macular edema after plaque radiotherapy for uveal melanoma: a pilot study. Retina 32:1601\u20131607","journal-title":"Retina"},{"key":"7010_CR58","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ijrobp.2014.02.021","volume":"89","author":"TA McCannel","year":"2014","unstructured":"McCannel TA, McCannel CA (2014) Iodine 125 brachytherapy with vitrectomy and silicone oil in the treatment of uveal melanoma: 1-to-1 matched case-control series. Int J Radiat Oncol Biol Phys 89:347\u2013352","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR59","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/eye.2012.249","volume":"27","author":"C Groenewald","year":"2013","unstructured":"Groenewald C, Konstantinidis L, Damato B (2013) Effects of radiotherapy on uveal melanomas and adjacent tissues. Eye (Lond) 27:163\u2013171","journal-title":"Eye (Lond)"},{"key":"7010_CR60","doi-asserted-by":"crossref","unstructured":"Konstantinidis L, Damato B (2013) Trans\u2010scleral local resection of toxic choroidal melanoma after proton beam radiotherapy. Acta ophthalmologica (Oxford, England) 91:0\u20130","DOI":"10.1111\/j.1755-3768.2013.S094.x"},{"key":"7010_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221810066","author":"MR Romano","year":"2021","unstructured":"Romano MR et al (2021) Vitreoretinal surgery in the prevention and treatment of toxic tumour syndrome in uveal melanoma: a systematic review. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms221810066","journal-title":"Int J Mol Sci"},{"key":"7010_CR62","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ijrobp.2006.08.080","volume":"67","author":"NMD Hirasawa","year":"2007","unstructured":"Hirasawa NMD et al (2007) Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose\u2013volume histogram analysis. Int J Radiat Oncol Biol Phys 67:538\u2013543","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR63","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ijrobp.2012.12.022","volume":"86","author":"SMD Toyama","year":"2013","unstructured":"Toyama SMD et al (2013) Long-term results of carbon ion radiation therapy for locally advanced or unfavorably located choroidal melanoma: usefulness of CT-based 2-port orthogonal therapy for reducing the incidence of neovascular glaucoma. Int J Radiat Oncol Biol Phys 86:270\u2013276","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR64","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ijrobp.2013.05.051","volume":"87","author":"KK Mishra","year":"2013","unstructured":"Mishra KK et al (2013) Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters. Int J Radiat Oncol Biol Phys 87:330\u2013336","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR65","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ophtha.2020.06.030","volume":"128","author":"CA Espensen","year":"2021","unstructured":"Espensen CA et al (2021) Dose-response and normal tissue complication probabilities after proton therapy for choroidal melanoma. Ophthalmology 128:152\u2013161","journal-title":"Ophthalmology"},{"key":"7010_CR66","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ophtha.2004.09.028","volume":"112","author":"ET Detorakis","year":"2005","unstructured":"Detorakis ET, Engstrom RE, Wallace R, Straatsma BR (2005) Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma. Ophthalmology 112:505\u2013510","journal-title":"Ophthalmology"},{"key":"7010_CR67","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S0360-3016(97)00557-9","volume":"39","author":"IK Daftari","year":"1997","unstructured":"Daftari IK et al (1997) Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma. Int J Radiat Oncol Biol Phys 39:997\u20131010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR68","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1136\/bjophthalmol-2017-310801","volume":"102","author":"CR Gigliotti","year":"2018","unstructured":"Gigliotti CR et al (2018) Predictors of radio-induced visual impairment after radiosurgery for uveal melanoma. Br J Ophthalmol 102:833\u2013839","journal-title":"Br J Ophthalmol"},{"key":"7010_CR69","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1007\/s00417-017-3737-3","volume":"255","author":"AI Riechardt","year":"2017","unstructured":"Riechardt AI et al (2017) Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors. Graefes Arch Clin Exp Ophthalmol 255:2263\u20132269","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7010_CR70","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1136\/bjo.81.9.748","volume":"81","author":"AJ Foss","year":"1997","unstructured":"Foss AJ et al (1997) Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma. Br J Ophthalmol 81:748\u2013754","journal-title":"Br J Ophthalmol"},{"key":"7010_CR71","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello LP et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480\u20131487","journal-title":"N Engl J Med"},{"key":"7010_CR72","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ijrobp.2010.04.073","volume":"80","author":"BFMDPD Fernandes","year":"2011","unstructured":"Fernandes BFMDPD et al (2011) Neovascular glaucoma after stereotactic radiotherapy for juxtapapillary choroidal melanoma: histopathologic and dosimetric findings. Int J Radiat Oncol Biol Phys 80:377\u2013384","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR73","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.radonc.2011.06.038","volume":"102","author":"K Muller","year":"2011","unstructured":"Muller K et al (2011) Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results. Radiother Oncol 102:219\u2013224","journal-title":"Radiother Oncol"},{"key":"7010_CR74","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijrobp.2005.01.050","volume":"63","author":"B Damato","year":"2005","unstructured":"Damato B et al (2005) Proton beam radiotherapy of iris melanoma. Int J Radiat Oncol Biol Phys 63:109\u2013115","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR75","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00417-017-3834-3","volume":"256","author":"A Mahdjoubi","year":"2018","unstructured":"Mahdjoubi A et al (2018) Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy. Graefes Arch Clin Exp Ophthalmol 256:411\u2013420","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7010_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225657","author":"J Pals","year":"2021","unstructured":"Pals J et al (2021) The effect of intraocular pressure-lowering medication on metastatic uveal melanomas. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13225657","journal-title":"Cancers (Basel)"},{"key":"7010_CR77","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jocn.2007.09.004","volume":"15","author":"HV Danesh-Meyer","year":"2007","unstructured":"Danesh-Meyer HV (2007) Radiation-induced optic neuropathy. J Clin Neurosci 15:95\u2013100","journal-title":"J Clin Neurosci"},{"key":"7010_CR78","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.ijrobp.2008.12.068","volume":"75","author":"Y Demizu","year":"2009","unstructured":"Demizu Y et al (2009) Analysis of vision loss caused by radiation-induced optic neuropathy after particle therapy for head-and-neck and skull-base tumors adjacent to optic nerves. Int J Radiat Oncol Biol Phys 75:1487\u20131492","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215327","author":"A K\u00f6the","year":"2021","unstructured":"K\u00f6the A et al (2021) Assessment of radiation-induced optic neuropathy in a multi-institutional cohort of chordoma and chondrosarcoma patients treated with proton therapy. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13215327","journal-title":"Cancers (Basel)"},{"key":"7010_CR80","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/APO.0000000000000271","volume":"9","author":"M Chang","year":"2020","unstructured":"Chang M et al (2020) Prophylactic intravitreal bevacizumab after plaque radiotherapy for uveal melanoma: analysis of visual acuity, tumor response, and radiation complications in 1131 eyes based on patient age. Asia-Pac J Ophthalmol 9:29\u201338","journal-title":"Asia-Pac J Ophthalmol"},{"key":"7010_CR81","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.ijrobp.2004.12.009","volume":"62","author":"N Bhandare","year":"2005","unstructured":"Bhandare N, Monroe AT, Morris CG, Bhatti MT, Mendenhall WM (2005) Does altered fractionation influence the risk of radiation-induced optic neuropathy? Int J Radiat Oncol Biol Phys 62:1070\u20131077","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR82","doi-asserted-by":"crossref","unstructured":"Carey AR, Page BR, N Miller (2022) Radiation-induced optic neuropathy: a review. Br J Ophthalmol bjo-2022\u2013322854","DOI":"10.1136\/bjo-2022-322854"},{"key":"7010_CR83","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1177\/11206721221085409","volume":"32","author":"CW Yu","year":"2022","unstructured":"Yu CW, Joarder I, Micieli JA (2022) Treatment and prophylaxis of radiation optic neuropathy: a systematic review and meta-analysis. Eur J Ophthalmol 32:3129\u20133141","journal-title":"Eur J Ophthalmol"},{"key":"7010_CR84","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/00041327-199709000-00022","volume":"17","author":"FX Borruat","year":"1997","unstructured":"Borruat FX, Schatz NJ, Glaser JS, Matos L, Feuer W (1997) Radiation optic neuropathy: report of cases, role of hyperbaric oxygen therapy, and literature review. J Neuro-Ophthalmol 17:221\u2013221","journal-title":"J Neuro-Ophthalmol"},{"key":"7010_CR85","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.aopr.2023.05.003","volume":"3","author":"Y Wang","year":"2023","unstructured":"Wang Y et al (2023) Clinical characteristics of radiation-induced optic neuropathy: a single-center retrospective study. Adv Ophthalmol Practice Res 3:141\u2013146","journal-title":"Adv Ophthalmol Practice Res"},{"key":"7010_CR86","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/01658107.2020.1817946","volume":"45","author":"FG Ata\u00eddes","year":"2021","unstructured":"Ata\u00eddes FG, Silva S, Baldin J (2021) Radiation-induced optic neuropathy: literature review. Neuroophthalmology 45:172\u2013180","journal-title":"Neuroophthalmology"},{"key":"7010_CR87","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1136\/bjophthalmol-2017-311389","volume":"102","author":"R Parrozzani","year":"2018","unstructured":"Parrozzani R et al (2018) Peripapillary vascular changes in radiation optic neuropathy: an optical coherence tomography angiography grading. Br J Ophthalmol 102:1238\u20131243","journal-title":"Br J Ophthalmol"},{"key":"7010_CR88","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/WNO.0000000000000670","volume":"39","author":"EL Archer","year":"2019","unstructured":"Archer EL, Liao EA, Trobe JD (2019) Radiation-induced optic neuropathy: clinical and imaging profile of twelve patients. J Neuro-Ophthalmol 39:170\u2013180","journal-title":"J Neuro-Ophthalmol"},{"key":"7010_CR89","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","volume":"79","author":"VA Levin","year":"2011","unstructured":"Levin VA et al (2011) Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys 79:1487\u20131495","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR90","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.ijrobp.2018.04.068","volume":"101","author":"Y Xu","year":"2018","unstructured":"Xu Y et al (2018) Bevacizumab monotherapy reduces radiation-induced brain necrosis in Nasopharyngeal carcinoma patients: a randomized controlled trial. Int J Radiat Oncol Biol Phys 101:1087\u20131095","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR91","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11060-023-04346-y","volume":"163","author":"AM AlAmeer","year":"2023","unstructured":"AlAmeer AM, Davis JB, Carey AR, Henderson AD (2023) Outcomes of systemic bevacizumab in radiation-induced optic neuropathy, case series. J Neurooncol 163:439\u2013446","journal-title":"J Neurooncol"},{"key":"7010_CR92","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ijrobp.2010.11.075","volume":"82","author":"PT Finger","year":"2012","unstructured":"Finger PT, Chin KJ (2012) Antivascular endothelial growth factor bevacizumab for radiation optic neuropathy: secondary to plaque radiotherapy. Int J Radiat Oncol Biol Phys 82:789\u2013798","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR93","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ajo.2019.07.004","volume":"208","author":"D Eckstein","year":"2019","unstructured":"Eckstein D et al (2019) Radiation-induced optic neuropathy: observation versus intravitreal treatment: can visual acuity be maintained by intravitreal treatment? Am J Ophthalmol 208:289\u2013294","journal-title":"Am J Ophthalmol"},{"key":"7010_CR94","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.ophtha.2009.12.015","volume":"117","author":"IK Kim","year":"2010","unstructured":"Kim IK, Lane AM, Egan KM, Munzenrider J, Gragoudas ES (2010) Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma. Ophthalmology 117:1617\u20131622","journal-title":"Ophthalmology"},{"key":"7010_CR95","doi-asserted-by":"publisher","first-page":"22419","DOI":"10.1038\/s41598-021-01844-9","volume":"11","author":"X Chen","year":"2021","unstructured":"Chen X et al (2021) Alterations in meibomian glands in patients treated with intensity-modulated radiotherapy for head and neck cancer. Sci Rep 11:22419\u201322419","journal-title":"Sci Rep"},{"key":"7010_CR96","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ijrobp.2008.08.010","volume":"74","author":"KMD Muller","year":"2009","unstructured":"Muller KMD et al (2009) Lacrimal gland radiosensitivity in uveal melanoma patients. Int J Radiat Oncol Biol Phys 74:497\u2013502","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR97","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1167\/tvst.6.3.19","volume":"6","author":"S Tiwari","year":"2017","unstructured":"Tiwari S et al (2017) Aqueous deficient dry eye syndrome post orbital radiotherapy: a 10-year retrospective study. Transl Vis Sci Technol 6:19\u201319","journal-title":"Transl Vis Sci Technol"},{"key":"7010_CR98","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ijrobp.2017.01.199","volume":"98","author":"J Thariat","year":"2017","unstructured":"Thariat J et al (2017) Dry eye syndrome after proton therapy of ocular melanomas. Int J Radiat Oncol Biol Phys 98:142\u2013151","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR99","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/eye.2009.43","volume":"23","author":"JC Wen","year":"2009","unstructured":"Wen JC, Oliver SC, McCannel TA (2009) Ocular complications following I-125 brachytherapy for choroidal melanoma. Eye 23:1254\u20131268","journal-title":"Eye"},{"key":"7010_CR100","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0161-6420(98)91123-X","volume":"105","author":"SK Kwok","year":"1998","unstructured":"Kwok SK et al (1998) An analysis of the incidence and risk factors of developing severe keratopathy in eyes after megavoltage external beam irradiation. Ophthalmology 105:2051\u20132055","journal-title":"Ophthalmology"},{"key":"7010_CR101","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/01.ico.0000154235.64359.d3","volume":"24","author":"S Barabino","year":"2005","unstructured":"Barabino S, Raghavan A, Loeffler J, Dana R (2005) Radiotherapy-induced ocular surface disease. Cornea 24:909\u2013914","journal-title":"Cornea"},{"key":"7010_CR102","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ijrobp.2019.02.005","volume":"104","author":"HJ Lee","year":"2019","unstructured":"Lee HJ et al (2019) Corneal substructure dosimetry predicts corneal toxicity in patients with uveal melanoma treated with proton beam therapy. Int J Radiat Oncol Biol Phys 104:374\u2013382","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR103","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.radonc.2019.07.022","volume":"141","author":"N Kubo","year":"2019","unstructured":"Kubo N et al (2019) Dosimetric parameters predictive of nasolacrimal duct obstruction after carbon-ion radiotherapy for head and neck carcinoma. Radiother Oncol 141:72\u201377","journal-title":"Radiother Oncol"},{"key":"7010_CR104","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.ophtha.2023.05.004","volume":"130","author":"K Eibenberger","year":"2023","unstructured":"Eibenberger K, Heimann H, Gatchalian L, Kacperek A, Hussain R (2023) Side effects of proton beam radiotherapy treatment on Iris melanoma. Ophthalmology 130:958\u2013965","journal-title":"Ophthalmology"},{"key":"7010_CR105","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/01676830.2017.1337182","volume":"36","author":"VAR Juniat","year":"2017","unstructured":"Juniat VAR, Rajak S (2017) The use of prophylactic nunchaku stents to reduce the risk of nasolacrimal duct obstruction in patients with midfacial tumours undergoing radiotherapy. Orbit 36:298\u2013300","journal-title":"Orbit"},{"key":"7010_CR106","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s00417-008-0920-6","volume":"246","author":"PP Radin","year":"2008","unstructured":"Radin PP et al (2008) Scleral necrosis after radiation therapy for uveal melanomas: report of 23 cases. Graefes Arch Clin Exp Ophthalmol 246:1731\u20131736","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7010_CR107","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.ophtha.2012.10.021","volume":"120","author":"SMD Kaliki","year":"2013","unstructured":"Kaliki SMD et al (2013) Scleral necrosis after plaque radiotherapy of uveal melanoma: a case-control study. Ophthalmology 120:1004\u20131011","journal-title":"Ophthalmology"},{"key":"7010_CR108","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/ceo.13928","volume":"49","author":"L Jabbarli","year":"2021","unstructured":"Jabbarli L et al (2021) Scleral necrosis after brachytherapy for uveal melanoma: analysis of risk factors. Clin Exp Ophthalmol 49:357\u2013367","journal-title":"Clin Exp Ophthalmol"},{"key":"7010_CR109","first-page":"1777","volume":"281","author":"K G\u00fcnd\u00fcz","year":"1999","unstructured":"G\u00fcnd\u00fcz K (1999) Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement. JAMA 281:1777","journal-title":"JAMA"},{"key":"7010_CR110","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/IAE.0b013e3181863f7c","volume":"29","author":"IA Chaudhry","year":"2009","unstructured":"Chaudhry IA et al (2009) Corneoscleral necrosis after episcleral au-198 brachytherapy of uveal melanoma. Retina 29:73\u201379","journal-title":"Retina"},{"key":"7010_CR111","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.ophtha.2005.10.059","volume":"113","author":"P Toivonen","year":"2006","unstructured":"Toivonen P, Kivel\u00e4 T (2006) Pigmented episcleral deposits after brachytherapy of uveal melanoma. Ophthalmology 113:865\u2013873","journal-title":"Ophthalmology"},{"key":"7010_CR112","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000481858","volume":"4","author":"DE Berry","year":"2018","unstructured":"Berry DE, Grewal DS, Mruthyunjaya P (2018) Conjunctival dehiscence and scleral necrosis following Iodine-125 plaque brachytherapy for uveal melanoma: a report of 3 cases. Ocul Oncol Pathol 4:291\u2013296","journal-title":"Ocul Oncol Pathol"},{"key":"7010_CR113","first-page":"29","volume":"77","author":"JM Caminal Mitjana","year":"2002","unstructured":"Caminal Mitjana JM, Quintana Casany M, Pera F\u00e1bregas J, Cinos Cope C, Guedea F (2002) Results of Iodine-125 radiotherapy in the treatment of uveal melanoma. Arch Soc Esp Oftalmol 77:29","journal-title":"Arch Soc Esp Oftalmol"},{"key":"7010_CR114","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ajo.2004.07.019","volume":"138","author":"EC Sener","year":"2004","unstructured":"Sener EC, Kiratli H, Gedik S, Sanac AS (2004) Ocular motility disturbances after episcleral plaque brachytherapy for uveal melanoma. Am J Ophthalmol 138:518\u2013518","journal-title":"Am J Ophthalmol"},{"key":"7010_CR115","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1016\/j.ophtha.2014.05.037","volume":"121","author":"ST Nagendran","year":"2014","unstructured":"Nagendran ST, Finger PT, Campolattaro BN (2014) Extraocular muscle repositioning and diplopia: associated with ophthalmic plaque radiation therapy for choroidal melanoma. Ophthalmology (Rochester, Minn) 121:2268\u20132274","journal-title":"Ophthalmology (Rochester, Minn)"},{"key":"7010_CR116","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jaapos.2007.04.005","volume":"11","author":"E Dawson","year":"2007","unstructured":"Dawson E et al (2007) Strabismus in adults with uveal melanoma following episcleral plaque brachytherapy. J AAPOS 11:584\u2013588","journal-title":"J AAPOS"},{"key":"7010_CR117","first-page":"27","volume":"6","author":"JP Bolling","year":"2022","unstructured":"Bolling JP et al (2022) Treatment of uveal melanoma with radioactive iodine 125 implant compared with proton beam radiotherapy. Mayo Clin Proc: Innovations, Quality & Outcomes 6:27\u201336","journal-title":"Mayo Clin Proc: Innovations, Quality & Outcomes"},{"key":"7010_CR118","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/09273970701431368","volume":"15","author":"H K\u00efratl\u00ef","year":"2007","unstructured":"K\u00efratl\u00ef H, Y\u00eflmaz PT, Sargon M (2007) Ultrastructural alterations in extraocular muscles following iodine-125 brachytherapy for uveal melanoma. Strabismus 15:103\u2013109","journal-title":"Strabismus"},{"key":"7010_CR119","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.ijrobp.2010.09.056","volume":"79","author":"VSEMP Jeganathan","year":"2011","unstructured":"Jeganathan VSEMP, Wirth AMDFRACPFRANZCR, MacManus MPMDFRANZCR (2011) Ocular risks from orbital and periorbital radiation therapy: a critical review. Int J Radiat Oncol Biol Phys 79:650\u2013659","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7010_CR120","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s13555-016-0120-y","volume":"6","author":"FN Bray","year":"2016","unstructured":"Bray FN, Simmons BJ, Wolfson AH, Nouri K (2016) Acute and chronic cutaneous reactions to ionizing radiation therapy. Dermatol Ther (Heidelb) 6:185\u2013206","journal-title":"Dermatol Ther (Heidelb)"},{"key":"7010_CR121","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3390\/cancers14051194","volume":"14","author":"J Thariat","year":"2022","unstructured":"Thariat J et al (2022) Non-cancer effects following ionizing irradiation involving the eye and orbit. Cancers 14:1194","journal-title":"Cancers"},{"key":"7010_CR122","doi-asserted-by":"crossref","unstructured":"Kamrava M, Lamb J, Sober\u00f3n V, McCannel TA. Ocular complications of radiotherapy. 117\u2013128 (Springer International Publishing, Cham, 2019)","DOI":"10.1007\/978-3-030-04489-3_12"},{"key":"7010_CR123","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0161-6420(96)30706-9","volume":"103","author":"SM Imhof","year":"1996","unstructured":"Imhof SM et al (1996) Quantification of orbital and mid-facial growth retardation after megavoltage external beam irradiation in children with retinoblastoma. Ophthalmology 103:263\u2013268","journal-title":"Ophthalmology"},{"key":"7010_CR124","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/BF01387319","volume":"26","author":"NC Yue","year":"1996","unstructured":"Yue NC, Benson ML (1996) The hourglass facial deformity as a consequence of orbital irradiation for bilateral retinoblastoma. Pediatr Radiol 26:421\u2013423","journal-title":"Pediatr Radiol"},{"key":"7010_CR125","first-page":"391","volume":"14","author":"C Mohr","year":"1990","unstructured":"Mohr C, Fritze H, Messmer E, Heinrich T (1990) The question of midface growth inhibition following retinoblastoma treatment in early childhood. Dtsch Z Mund Kiefer Gesichtschir 14:391\u2013394","journal-title":"Dtsch Z Mund Kiefer Gesichtschir"},{"key":"7010_CR126","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.survophthal.2021.01.008","volume":"66","author":"A Martel","year":"2021","unstructured":"Martel A et al (2021) Orbital exenteration: an updated review with perspectives. Surv Ophthalmol 66:856\u2013876","journal-title":"Surv Ophthalmol"},{"key":"7010_CR127","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3109\/01676830.2014.884604","volume":"33","author":"NM Peter","year":"2014","unstructured":"Peter NM, Laitt R, Leatherbarrow B (2014) Osteoradionecrosis of the exenterated orbit. Orbit (Amsterdam) 33:220\u2013222","journal-title":"Orbit (Amsterdam)"},{"key":"7010_CR128","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/aos.13729","volume":"96","author":"DL Mourits","year":"2018","unstructured":"Mourits DL et al (2018) Cosmetic results of enucleation and\/or external beam radiation therapy in 195 retinoblastoma survivors. Acta ophthalmologica (Oxford, England) 96:631\u2013640","journal-title":"Acta ophthalmologica (Oxford, England)"},{"key":"7010_CR129","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/IOP.0b013e31824dd9b8","volume":"28","author":"QJ Nasser","year":"2012","unstructured":"Nasser QJ et al (2012) Management of radiation-induced severe anophthalmic socket contracture in patients with uveal melanoma. Ophthalmic Plast Reconstr Surg 28:208\u2013212","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"7010_CR130","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","volume":"12","author":"ABD de Gonzalez","year":"2011","unstructured":"de Gonzalez ABD et al (2011) Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol 12:353\u2013360","journal-title":"Lancet Oncol"},{"key":"7010_CR131","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/pbc.26193","volume":"64","author":"P Temming","year":"2017","unstructured":"Temming P et al (2017) Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center. Pediatr Blood Cancer 64:71\u201380","journal-title":"Pediatr Blood Cancer"},{"key":"7010_CR132","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1200\/JCO.2005.05.054","volume":"23","author":"RA Kleinerman","year":"2005","unstructured":"Kleinerman RA et al (2005) Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 23:2272\u20132279","journal-title":"J Clin Oncol"},{"key":"7010_CR133","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1200\/JCO.2005.03.8349","volume":"24","author":"S Sharif","year":"2006","unstructured":"Sharif S et al (2006) Second Primary Tumors in Neurofibromatosis 1 Patients Treated for Optic Glioma: Substantial Risks After Radiotherapy. J Clin Oncol 24:2570\u20132575","journal-title":"J Clin Oncol"},{"key":"7010_CR134","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/cncr.28387","volume":"120","author":"RVRV Sethi","year":"2013","unstructured":"Sethi RVRV et al (2013) Second non-ocular tumors among survivors of retin","journal-title":"Cancer"},{"key":"7010_CR135","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1055\/s-0040-1713894","volume":"81","author":"M Ioakeim-Ioannidou","year":"2020","unstructured":"Ioakeim-Ioannidou M, MacDonald SM (2020) Evolution of care of orbital tumors withradiation therapy. J Neurological Surg Part B, Skull base 81:480\u2013496","journal-title":"J Neurological Surg Part B, Skull base"},{"key":"7010_CR136","doi-asserted-by":"crossref","unstructured":"Farazdaghi MK, Katowitz WR, Avery RA (2019) Current treatment of optic nervegliomas. Curr Opin Ophthalmol 30:356\u2013363","DOI":"10.1097\/ICU.0000000000000587"},{"key":"7010_CR137","doi-asserted-by":"crossref","unstructured":"Tsang DS, Murphy ES, Merchant TE (2017) Radiation therapy for optic pathway and hypothalamic low-grade gliomas in children. Int J Radiat Oncol Biol Phys 99:642\u2013651","DOI":"10.1016\/j.ijrobp.2017.07.023"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07010-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-07010-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07010-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:03:08Z","timestamp":1772794988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-07010-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":137,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["7010"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-07010-5","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organisation or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"There were no human or animal participants in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"There were no human participants in this study, so informed consent did not apply.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Ethical approval was not required for this study, as it is a review of previously published literature and does not involve any human participants, animal subjects, or identifiable personal data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}